Member Companies

Current


Alumni

gritstone-logo

 
editas-logocrispr-logo

Testimonials

“The turnkey operational support from Mass Innovation Labs enabled us to get up and running quickly, expand our team and focus on hitting key milestones we make headway on our breakthrough approach in gene-editing CRISPR-Cas 9.”
Dr. Bill Lundberg, chief scientific officer of CRISPR Therapeutics
Thompson Reuters May 2015
 
“Mass Innovation Labs provides an ideal space within the leading scientific community of Kendall Square for us to conduct our research. They made it possible to reduce the standard start-up time by several months, supporting rapid initiation of our research program to bring personalized cancer immunotherapies to patients. Having the ability to begin work so quickly is like being able to buy time.”
Andrew Allen, M.D., Ph.D
Co-founder, President and CEO of Gritstone Oncology
 
“The time between receiving funding to occupying our space at Mass Innovation Labs was remarkably short. The time we saved by choosing Mass Innovation Labs for our lab program is invaluable, allowing us to move ahead with our research at a critical time in our development.”
Jason Fisherman, M.D.
CEO of C4 Therapeutics
 
“Since joining the Mass Innovation Jumpstart Program in August 2015, we were able to quickly set up our laboratory, advancing our hiring process three months ahead of plan. We look forward to continuing to utilize Mass Innovations Labs space to accelerate our work in precision biologic therapeutics for immuno-oncology, autoimmunity and other diseases.”
Ron Seidel, Ph.D.
Head of Research and Development at Imagen Biopharma